Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability

Alessandra Verdina, Irene Cardillo, Angela Nebbioso, Rossella Galati, Simona Menegozzo, Lucia Altucci, Ada Sacchi, Alfonso Baldi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed for prevention and treatment of a variety of human cancers. Piroxicam, in particular, has been recently shown to exert significant anti-tumoral activity in combination with cisplatin (CDDP) on mesothelioma cells. However, the mechanisms through which NSAIDs regulate the cell cycle as well as the signal pathways involved in the growth inhibition, remain unclear. In the present study, using two mesothelioma cell lines, MSTO-211H and NCI-H2452, we have investigated the influence of piroxicam alone and in association with CDDP on proliferation, cell cycle regulation and apoptosis. In both cell lines a significant effect on cell growth inhibition, respect to the control, was observed with all the drugs tested. Moreover, treatment with piroxicam or CDDP alone altered the cell cycle phase distribution as well as the expression of some cell cycle regulatory proteins in both cell lines. These effects were increased, even if in a not completely overlapping manner, after treatment with the association of piroxicam and CDDP. In particular, the two drugs in NCI cell line had a synergistic effect on apoptosis, probably through activation of caspase 8 and caspase 9, while the most evident targets among the cell cycle regulators were cyclin D1 and p21waf1. These results suggest that the association of piroxicam and CDDP specifically triggers cell cycle regulation and apoptosis in different mesothelioma cell lines and may hold promise in the treatment of mesothelioma.

Original languageEnglish
Article number27
JournalJournal of Translational Medicine
Volume6
DOIs
Publication statusPublished - May 22 2008

Fingerprint

Piroxicam
Mesothelioma
Cell growth
Cisplatin
Cell Survival
Cell Cycle
Cells
Cell Line
Growth
Apoptosis
Pharmaceutical Preparations
Anti-Inflammatory Agents
Cell Cycle Proteins
Association reactions
Caspase 9
Caspase 8
Cyclin D1
Signal Transduction
Cell proliferation
Neoplasms

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability. / Verdina, Alessandra; Cardillo, Irene; Nebbioso, Angela; Galati, Rossella; Menegozzo, Simona; Altucci, Lucia; Sacchi, Ada; Baldi, Alfonso.

In: Journal of Translational Medicine, Vol. 6, 27, 22.05.2008.

Research output: Contribution to journalArticle

Verdina, Alessandra ; Cardillo, Irene ; Nebbioso, Angela ; Galati, Rossella ; Menegozzo, Simona ; Altucci, Lucia ; Sacchi, Ada ; Baldi, Alfonso. / Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability. In: Journal of Translational Medicine. 2008 ; Vol. 6.
@article{9be642832dd04b9f8dca4b7fe45df2f3,
title = "Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability",
abstract = "Nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed for prevention and treatment of a variety of human cancers. Piroxicam, in particular, has been recently shown to exert significant anti-tumoral activity in combination with cisplatin (CDDP) on mesothelioma cells. However, the mechanisms through which NSAIDs regulate the cell cycle as well as the signal pathways involved in the growth inhibition, remain unclear. In the present study, using two mesothelioma cell lines, MSTO-211H and NCI-H2452, we have investigated the influence of piroxicam alone and in association with CDDP on proliferation, cell cycle regulation and apoptosis. In both cell lines a significant effect on cell growth inhibition, respect to the control, was observed with all the drugs tested. Moreover, treatment with piroxicam or CDDP alone altered the cell cycle phase distribution as well as the expression of some cell cycle regulatory proteins in both cell lines. These effects were increased, even if in a not completely overlapping manner, after treatment with the association of piroxicam and CDDP. In particular, the two drugs in NCI cell line had a synergistic effect on apoptosis, probably through activation of caspase 8 and caspase 9, while the most evident targets among the cell cycle regulators were cyclin D1 and p21waf1. These results suggest that the association of piroxicam and CDDP specifically triggers cell cycle regulation and apoptosis in different mesothelioma cell lines and may hold promise in the treatment of mesothelioma.",
author = "Alessandra Verdina and Irene Cardillo and Angela Nebbioso and Rossella Galati and Simona Menegozzo and Lucia Altucci and Ada Sacchi and Alfonso Baldi",
year = "2008",
month = "5",
day = "22",
doi = "10.1186/1479-5876-6-27",
language = "English",
volume = "6",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Molecular analysis of the effects of Piroxicam and Cisplatin on mesothelioma cells growth and viability

AU - Verdina, Alessandra

AU - Cardillo, Irene

AU - Nebbioso, Angela

AU - Galati, Rossella

AU - Menegozzo, Simona

AU - Altucci, Lucia

AU - Sacchi, Ada

AU - Baldi, Alfonso

PY - 2008/5/22

Y1 - 2008/5/22

N2 - Nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed for prevention and treatment of a variety of human cancers. Piroxicam, in particular, has been recently shown to exert significant anti-tumoral activity in combination with cisplatin (CDDP) on mesothelioma cells. However, the mechanisms through which NSAIDs regulate the cell cycle as well as the signal pathways involved in the growth inhibition, remain unclear. In the present study, using two mesothelioma cell lines, MSTO-211H and NCI-H2452, we have investigated the influence of piroxicam alone and in association with CDDP on proliferation, cell cycle regulation and apoptosis. In both cell lines a significant effect on cell growth inhibition, respect to the control, was observed with all the drugs tested. Moreover, treatment with piroxicam or CDDP alone altered the cell cycle phase distribution as well as the expression of some cell cycle regulatory proteins in both cell lines. These effects were increased, even if in a not completely overlapping manner, after treatment with the association of piroxicam and CDDP. In particular, the two drugs in NCI cell line had a synergistic effect on apoptosis, probably through activation of caspase 8 and caspase 9, while the most evident targets among the cell cycle regulators were cyclin D1 and p21waf1. These results suggest that the association of piroxicam and CDDP specifically triggers cell cycle regulation and apoptosis in different mesothelioma cell lines and may hold promise in the treatment of mesothelioma.

AB - Nonsteroidal anti-inflammatory drugs (NSAIDs) have been proposed for prevention and treatment of a variety of human cancers. Piroxicam, in particular, has been recently shown to exert significant anti-tumoral activity in combination with cisplatin (CDDP) on mesothelioma cells. However, the mechanisms through which NSAIDs regulate the cell cycle as well as the signal pathways involved in the growth inhibition, remain unclear. In the present study, using two mesothelioma cell lines, MSTO-211H and NCI-H2452, we have investigated the influence of piroxicam alone and in association with CDDP on proliferation, cell cycle regulation and apoptosis. In both cell lines a significant effect on cell growth inhibition, respect to the control, was observed with all the drugs tested. Moreover, treatment with piroxicam or CDDP alone altered the cell cycle phase distribution as well as the expression of some cell cycle regulatory proteins in both cell lines. These effects were increased, even if in a not completely overlapping manner, after treatment with the association of piroxicam and CDDP. In particular, the two drugs in NCI cell line had a synergistic effect on apoptosis, probably through activation of caspase 8 and caspase 9, while the most evident targets among the cell cycle regulators were cyclin D1 and p21waf1. These results suggest that the association of piroxicam and CDDP specifically triggers cell cycle regulation and apoptosis in different mesothelioma cell lines and may hold promise in the treatment of mesothelioma.

UR - http://www.scopus.com/inward/record.url?scp=44949244913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44949244913&partnerID=8YFLogxK

U2 - 10.1186/1479-5876-6-27

DO - 10.1186/1479-5876-6-27

M3 - Article

C2 - 18498639

AN - SCOPUS:44949244913

VL - 6

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

M1 - 27

ER -